Prime Medicine, Inc. shares rise 7.85% intraday after presenting at Citi's Biopharma Back to School event.

miércoles, 3 de septiembre de 2025, 3:52 pm ET1 min de lectura
PRME--
Prime Medicine, Inc. rose 7.85% intraday, with the company presenting at Citi's Biopharma Back to School Forum. The presentation featured Allan Reine, CEO of Prime Medicine, and Greg Dearborn, Head of IR, who discussed the company's progress and future prospects.

Prime Medicine, Inc. shares rise 7.85% intraday after presenting at Citi's Biopharma Back to School event.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios